InSitu Biologics - AnestaGel™ - Eliminate the need for addictive opiates for pain management after surgery.
AnestaGel™ is a non-opioid pain relief drug based on technology created by scientists at the Cleveland Clinic. This paradigm shift is in the early stages of an annual $90 billion market opportunity.
They have already raised more than $1.7 million in a short period. InSitu Biologics is accepting a limited amount of investments at $6.85 per share.
View their Offering Circular HERE
Talketh - The first telephone network on the blockchain.
Talketh is a smartphone communications platform powered by the blockchain. It provides low-cost internet call capabilities on slow (& fast) internet connections worldwide without the need for bank accounts;1.5 bill Audience.
Own the first Blockchain system to be approved by the Swiss Regulators using their Feb 2018 rules system.
Open Labs - Disrupting the global skincare industry via the blockchain and an ingenious token reward system. 120,000 members.
Their sophisticated token-based ecosystem pays users for participating at all levels.
Open Labs are showing excellent traction worldwide with rapid growth and engagement. The Open Labs Network leverages the blockchain well and is a thoroughly developed system.
Image - Own Augmented Digital Imaging
Each image becomes a standalone content store, including text, audio, video, and URL. And the photos can be shared on social media.
Commercial solid use cases in 6 large and growing markets.
Radiant Pain Relief Centres - Successful Pain Treatment Without Needles or Drugs. Accepting Reservations now for their intended Reg A+ offering.
Radiant Pain Relief Centres provide a new way to relieve chronic pain - its exclusive direct-to-consumer business is built around a novel Patent Protected FDA-cleared device and a highly refined care model.
Brendon Lundberg, co-founder of Radiant Pain Relief has launched his Amazon best-selling book called Radiant Relief: A Case for a Better Solution to Chronic Pain.
Note that Manhattan Street Capital receives payments from companies that raise capital on our website. See the Manhattan Street Capital terms
All the best,
Rod Turner
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital service for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies including Symantec/Norton (SYMC), Ashton Tate, MicroPort, Knowledge Adventure, and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves, and eASIC.
www.ManhattanStreetCapital.com
Manhattan Street Capital, 5694 Mission Center Rd, Suite 602-468, San Diego, CA 92108.